The Challenges With Ensuring the Validity and Utility of Diagnostic Tests

Segment 3: The Trouble with Prognostic Tests
January 28, 2015 – 
Payers differentiate between predictive and prognostic diagnostic tests, and one is definitely more useful than the other, according to John L. Fox, MD, MHA, of Priority Health, and Bryan Loy, MD, MBA, of Humana.
Segment 12: Using Diagnostic Tests More Thoughtfully
January 28, 2015 – 
Using diagnostic tests thoughtfully becomes more difficult when demand is being driven by laboratories marketing the tests and patients who say they want the test, according to Francisco J. Esteva, MD, PhD, and Bryan Loy, MD, MBA.
Segment 13: Final Thoughts on Clinical Diagnostic Tests
January 28, 2015 – 
The panelists share their thoughts on the future of diagnostic tests and what changes they are looking forward to, such as developing better systems to integrate clinical information with molecular data and increased FDA oversight.
Segment 11: Two Paradigms Being Presented in Medical Oncology
January 28, 2015 – 
Daniel F. Hayes, MD, outlines the 2 paradigms presented in medical oncology: one where people would rather be overtreated rather than miss a chance to benefit by being undertreated and another where a person might not be willing to do something until they learn there is a reason to do so.
Segment 10: The Important Distinction Between Diagnostic, Screening Tests
January 28, 2015 – 
There is an important distinction between diagnostic and screening tests, and they have different issues in regards to decision making-although the person making treatment decisions should ultimately be guiding the ship, according to Bryan Loy, MD, MBA.
Segment 9: Who Should Order the Test?
January 28, 2015 – 
Both Francisco J. Esteva, MD, PhD, and Daniel F. Hayes, MD, agree that the role of genetic counselors should be limited when order diagnostic tests in medical oncology.
Segment 8: Challenges of Ordering, Paying for Diagnostic Tests
January 28, 2015 – 
When tests with clinical utility haven't made it onto the guidelines yet, what should payers do?
Segment 7: Guidelines for Diagnostic Test Use
January 28, 2015 – 
The panelists discuss guidelines for diagnostic test use and the biggest challenge from a payer standpoint.
Segment 6: Learning About CancerLinQ as It Rolls Out
January 28, 2015 – 
Daniel Hayes, MD, explains the implementation of the American Society of Clinical Oncology's CancerLinQ for beta testing.
Segment 5: Proper Use of Tests
January 28, 2015 – 
Bryan Loy, MD, MBA, discusses how payers can measure diagnostic test use and results, and Daniel Hayes, MD, weighs in with how CancerLinQ from the American Society of Clinical Oncology can help.
Copyright AJMC 2006-2018 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.

Sign In

Not a member? Sign up now!